Soonbum Kwon
Overview
Explore the profile of Soonbum Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banks D, Kempf J, Du Y, Reichert P, Narasimhan C, Fang R, et al.
Mol Pharm
. 2024 Nov;
21(12):6363-6375.
PMID: 39555969
The success of modern biopharmaceutical products depends on enhancing the stability of protein therapeutics. Freezing and thawing, which are common thermal stresses encountered throughout the lifecycle of drug substances, spanning...
2.
Kwon S, Meng F, Tamam H, Gadalla H, Wang J, Dong B, et al.
ACS Nano
. 2024 Jan;
18(4):3681-3698.
PMID: 38227965
Local delivery of immune-activating agents has shown promise in overcoming an immunosuppressive tumor microenvironment (TME) and stimulating antitumor immune responses in tumors. However, systemic therapy is ultimately needed to treat...
3.
Le H, Nguyen H, Min H, Hyun S, Kwon S, Lee Y, et al.
Cancer Lett
. 2023 Jul;
568:216289.
PMID: 37423849
No abstract available.
4.
Shen Y, Yuk S, Kwon S, Tamam H, Yeo Y, Han B
J Control Release
. 2023 Apr;
357:484-497.
PMID: 37068522
Many drugs are poorly water-soluble and suffer from low bioavailability. Metal-phenolic network (MPN), a hydrophilic thin layer such as tannic acid (TA)-Fe network, has been recently used to encapsulate hydrophobic...
5.
Jo J, Jeon Y, Kim D, Yang D, Lee W, Choi Y, et al.
Expert Opin Biol Ther
. 2023 Feb;
23(8):737-747.
PMID: 36757373
Background: CT-P10 was the first licensed rituximab biosimilar. This Korean post-marketing surveillance study evaluated CT-P10 safety and effectiveness in approved indications. Research Design And Methods: This prospective, open-label, observational, phase...
6.
Shin S, Kwon S, Yeo Y
Pharm Res
. 2022 Feb;
39(6):1085-1114.
PMID: 35146592
This meta-analysis aims to evaluate the trend, methodological quality and completeness of studies on intracellular delivery of antimicrobial agents. PubMed, Embase, and reference lists of related reviews were searched to...
7.
Kim H, Yuk S, Dieterly A, Kwon S, Park J, Meng F, et al.
ACS Nano
. 2021 Mar;
15(3):4576-4593.
PMID: 33645963
For systemic delivery of small interfering RNA (siRNA) to solid tumors, the carrier must circulate avoiding premature degradation, extravasate and penetrate tumors, enter target cells, traffic to the intracellular destination,...
8.
Bach D, Kim D, Bae S, Kim W, Hong J, Lee H, et al.
Mol Ther Nucleic Acids
. 2018 Jun;
11:455-467.
PMID: 29858080
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are used clinically as target therapies for lung cancer patients, but the occurrence of acquired drug resistance limits their efficacy. Nicotinamide N-methyltransferase...
9.
Le H, Nguyen H, Min H, Hyun S, Kwon S, Lee Y, et al.
Cancer Lett
. 2018 Mar;
424:136.
PMID: 29573834
No abstract available.
10.
Kwon S, Lee Y, Jung Y, Kim J, Baek B, Lim B, et al.
Eur J Med Chem
. 2018 Feb;
148:116-127.
PMID: 29454916
To achieve efficient photodynamic activity, substantial effort has been dedicated to precise control of the intracellular localization of current photosensitizers (PSs). Given the extremely small radius of action of singlet...